Connect with us

Technology

Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World’s Premier Healthcare Transformation Event

Published

on

Kingdom of Saudi Arabia opens the Global Health Exhibition (21-23 October 2024) tomorrow, a major international healthcare event with 100,000+ health and patient care stakeholders in attendance alongside over 1,200 exhibiting companies and brands, including Abbott, Baxter, Siemens, Zimmer Biomet, Johnson & Johnson and many moreExhibition features over 500 expert speakers across five healthcare disciplines, introducing frontier-pushing medical technology alongside 100 hours of accredited CME opportunities for medical professionals; as well as openings for healthcare startup businesses to capture the attention of investorsExhibition will offer attendees exposure to the latest artificial intelligence (AI) solutions being introduced to healthcare services, designed to transform the global medicine landscape alongside the latest augmented and virtual reality medical technologyExhibition sponsors include Saudi Commission for Health Specialities as the Strategic Partner; Health Holding, NUPCO, Mobily and Lean as Foundation Partners; STC as Digital Enabler; and Dallah Health and Tawuniya as Diamond SponsorsThe 7th Edition of the Global Health Exhibition is now set to become one of the top three most-attended healthcare forums worldwide

MALHAM, Saudi Arabia, Oct. 20, 2024 /PRNewswire/ — Tahaluf, organizers of the Global Health Exhibition, today announced advance registrations for the event opening in Riyadh tomorrow have surpassed expected attendance, making the international exhibition a major moment in the global healthcare professional and industry calendar.

The three-day exhibition, taking place in Malham, Riyadh under the patronage of the Saudi Arabia Ministry of Health, has more than doubled in size from its previous 2023 event, giving attendees access to an unprecedented number of world-leading healthcare and medical experts including Jeff Immelt, former CEO of General Electric and Venture Partner at New Enterprise Associates, Dr Mehmood Khan, CEO, Hevolution Foundation Saudi Arabia; Prof. Catherine Green OBE, Head of the Clinical BioManufacturing Facility at the University of Oxford; Dr Beth Healey, expedition doctor for National Geographic, clinical director at the University Hospitals of Geneva and former research MD for the European Space Agency; Dr Mariam Al Rashed Mehairbi, Regional Chief Medical Officer, Al Dhafra Hospitals; Dr Jose Pedro Almeida, a Chief AI Strategist and advisor, and one of the World’s Top 70 Global Health AI Brains and Dr Mohammad Al-Haddad MD, MSc, FASGE, FACG, AGAF, Division Director and Professor of Medicine at the IU School of Medicine. They will be joined by impressive Saudi leaders and healthcare experts including His Excellency Fahad bin Abdurrahman Al-Jalajel, Minister, Ministry of Health, Saudi Arabia;  Dr Aws bin Ibrahim Al-Shamsan, Secretary General, Saudi Commission for Health Specialities (SCFHS) and Fahad M. Alshebel, CEO, NUPCO.

The Exhibition’s sponsors include Saudi Commission for Health Specialities as the Strategic Partner, Health Holding, NUPCO, Mobily and Lean as Foundation Partners, STC as Digital Enabler and Dallah Health and Tawuniya as Diamond Sponsors.

Experts will discuss boundary-pushing trends in AI and digital technology set to evolve the global healthcare landscape, under its organizing theme ‘Invest in Health’.

“The Saudi Commission for Health Specialties (SCFHS) is steadfast in its mission to redefine healthcare education through the integration of innovative strategies and state-of-the-art technologies,” said Professor Aws Al-Shamsan, Secretary-General, Saudi Commission for Health Specialties.

“At the 2024 Global Health Exhibition, themed ‘Invest in Health’, we are championing the development of AI-powered training modules and systems designed to equip practitioners with the advanced skills and expertise necessary to navigate the complexities of a rapidly evolving healthcare landscape”, he continued. “By harnessing AI-driven insights, healthcare practitioners can improve patient care and optimize operational efficiency, ensuring they are well-prepared for the future of the industry.”

The Global Health Exhibition will comprise of five specific conferences along with exclusive masterclasses for attendees.

The Leaders’ Summit will host 1,000 delegates daily, featuring major announcements, ministerial sessions outlining the future vision for Saudi Arabia’s healthcare sector, and insights from innovators, changemakers, international policymakers, and leading global industry CEOs. Speakers will include leaders from the Africa Centre for Diseases Control and Prevention, Mayo Clinic, University of Oxford, Mass General Brigham, World Health Organisation, Dana-Farber Cancer Institute, the NHS and The Organisation for Economic Co-operation and Development.

A Medical Excellence Forum will cover technical advancements in clinical laboratory practices and diagnostics, the personalization of medicine to improve patient outcomes, and strategies for attracting and retaining healthcare talent for excellence in nursing and workforce. The forum will hear from Bumrungrad Hospital International, Johnson & Johnson Innovative Medicine, Philips, Massachusetts General Hospital, Harvard Medical School, University Health Network Canada and Siemens Healthineers. Insights will be aimed at a diverse audience of healthcare professionals from clinicians, doctors and nurses through to diagnostic imaging specialists and surgeons.

A new Digital Health Forum driven by Saudi Arabia’s Vision 2030 to advance digital healthcare solutions will explore the optimization of healthcare intelligence including the transformative potential of AI diagnostics, the leveraging of health data insights to enhance patient outcomes, and the future of technology roadmaps to assist healthcare providers to offer patient-centric personalized care. Speakers will include experts from Northwell Health, Great Ormond Street Hospital, NHS Trusts, John Hopkins, Health Innovation Kent, M42 and Operose Health.

An Investor Forum will offer attendees the opportunity to explore the emerging global healthcare investment in Saudi Arabia. It will highlight the future investment and development strategies and prospects aligned with Vision 2030, highlight the current innovations in healthcare technology across vaccines, pharmaceuticals and healthcare devices, and explore the strengthening of the global healthcare supply chain. The forum will hear from 30+ investor speakers, including leaders from Bayer, Deerfield Management, ABRA Ventures, the Ministry of Investment, Seafund, Candesic and Hitachi Ventures.

A Health Transformation Forum will draw on technological advancements in promoting patient safety, accuracy and diagnostic outcomes across the three days. Day one will partner with the Saudi Patient Safety Centre to tackle the challenges, strategies and innovations involved in enhancing diagnostic safety; day two will partner with the Saudi Commission for Health Specialities to cover innovations in medical examinations, optimization in healthcare regulation, and cutting-edge accreditation processes, including virtual health hospitals, and day three will partner with The Centre for Value in Health to measure value by combining quantitative data with qualitative insights to drive better health outcomes.

The exhibition will also offer free exclusive masterclasses for attendees, including The Future Innovation of Diagnostics in Saudi Arabia hosted by Danaher, Building Next-Generation Healthcare Systems hosted by FTI Consulting, and Precision Exposomics / Genomics: Breakthrough Technology hosted by Novo Genomics. This will run alongside 100 hours of accredited CME workshops for medical professionals amongst attendees.

“Interest in this year’s Global Health Exhibition has significantly exceeded expectations and we are excited to be bringing such a vast array of healthcare talent, competence and passion to Riyadh for three days of interactive engagement,” said Rachel Sturgess, Group Director, Tahaluf.

“With a dual focus on the needs of medical professionals who care for patients daily and the booming health industry sector’s growing investment in Saudi Arabia, the stage is set for a pivotal moment in world medicine as we collectively reimagine what’s possible across digital and remote health provision, industry innovation and world class healthcare systems. It’s a unique opportunity for collaboration, to adapt best practice, and explore innovative solutions for tackling disease prevention, encouraging accessibility to the best health services and championing technology-driven innovation, with the aim of accelerating transformation in global healthcare and outcomes for patients.”

The event will also unveil the winners of the Vision NextGen competition, where startup health businesses will compete for a cash prize of a minimum of 100,000 SAR, incubation in the Regulatory Sandbox where 18 government and semi-government collaborate to enable innovation in healthcare, an exhibition booth at next year’s Global Health Exhibition, and invaluable networking opportunities. The Vision NextGen competition semi-finalists include a range of impressive and innovative healthcare businesses such as NoorDx Diagnostics and Discovery, RobotDreams, StoreGene, Stabilis Medical and Thriving.AI.

The increasing demand for healthcare services in Saudi Arabia is fuelling a need for advanced medical and healthcare services, offering vast market potential for global companies. The country is focusing on adopting cutting-edge technologies such as a strategic hub for reaching other emerging markets in the region, while their pharmaceutical market is expected to grow to $15.9 billion by 2027, driven by the $65 billion investment into healthcare infrastructure. Saudi Arabia contributes 60% of the GCC’s healthcare expenditure and is projected to see a 65% increase in private sector healthcare investment by 2030. The Global Health Exhibition is the gateway into Saudi Arabia’s booming healthcare market for the international healthcare world.

Registration information for Global Health Exhibition 2024 can be found at the following link: Global Health Exhibition (globalhealthsaudi.com)

View original content:https://www.prnewswire.co.uk/news-releases/global-health-exhibition-opens-its-doors-tomorrow-to-record-breaking-100-000-attendees-to-worlds-premier-healthcare-transformation-event-302281169.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Wikipedia and Reddit Now Drive Over 25% of ChatGPT Citations in the U.S., New 5W Research Finds — WSJ, NYT, and Bloomberg Do Not Appear in the Top 20

Published

on

By

The 5W Citation Source Audit Q1 2026 synthesizes nine independent datasets covering hundreds of millions of citations and prompts. The data confirms a structural break between the traditional PR tier system and how ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews actually assemble answers.

MIAMI, May 11, 2026 /PRNewswire/ — 5W, the AI Communications Firm, today released The 5W Citation Source Audit – Q1 2026, a synthesis of nine independent research datasets — from Similarweb, SEMrush, Profound, Peec AI, SE Ranking, Goodie, Ahrefs, Evertune, and Passionfruit — quantifying which sources the major AI engines actually cite. The full report is available at 5wpr.com/research/citation-source-audit-q1-2026.

The headline data:

Wikipedia (13.15%) and Reddit (11.97%) together account for more than 25% of all ChatGPT citations in the U.S. (Similarweb, Jan–Feb 2026, ~600,000 citation events).The Wall Street Journal, The New York Times, Bloomberg, and the Financial Times do not appear in the top 20. Forbes is the only U.S. business publication on the list — ranked #18 at 1.38%.Reuters (#7, 2.27%) outranks Forbes. Forbes outranks every other Tier 1 outlet.YouTube correlates at 0.737 with AI visibility — the strongest single predictor in any 2025–2026 study (Ahrefs, 75,000-brand analysis, December 2025).LinkedIn moved from #11 to #5 on ChatGPT in three months — the largest rank shift Profound observed all year. LinkedIn is now cited in 14.3% of ChatGPT Search responses (SEMrush, 325,000 prompts).Reddit’s ChatGPT citation share collapsed from ~60% to ~10% of prompt responses in two weeks in September 2025 (SEMrush, 230,000-prompt 13-week tracking study). Annual AI audits are obsolete.Fandom leads Google AI Mode at 7.16% — ahead of Wikipedia. Structure plus depth beats brand authority.Brands listed across G2, Capterra, Trustpilot, and Yelp see a ~3x citation multiplier versus brands without those profiles.

“The PR tier hierarchy no longer reflects how influence works,” said Ronn Torossian, founder of 5W. “AI engines don’t rank authority — they assemble answers. They pull from Wikipedia, Reddit, LinkedIn, YouTube, and review platforms, and they ignore most of what the industry has spent forty years optimizing toward. The brands that win the next decade will be the ones whose names appear, consistently, in the structured surfaces the models actually retrieve from. That is the entire game now — and the data in this report is the operating manual.”

The Five Core Findings

Wikipedia + Reddit = Structural Dominance. Over 25% of ChatGPT citations in the U.S. Together they exceed every traditional media category combined.The PR Tier System Is Misaligned with AI Reality. Reuters outranks Forbes. Forbes outranks the rest. WSJ, NYT, Bloomberg, and FT often don’t appear at all.AI Citations Are Long-Tail, Not Winner-Take-All. Outside Wikipedia and Reddit, no domain exceeds 3% of ChatGPT citations. Distribution across many sources outperforms concentration in a few.Platforms Are Volatile. Reddit’s ChatGPT share dropped from ~60% to ~10% in two weeks in September 2025. Static strategies fail. Quarterly is the floor.Each AI Engine Is Different. Reddit leads everywhere. Fandom leads Google AI Mode. Perplexity skews to LinkedIn, NIH, and G2. Gemini converts traditional SEO. There is no single “AI SEO.”

Methodology

The Q1 2026 edition is a synthesis report. 5W integrated nine separately published studies covering January 2025 through April 2026 — including Similarweb’s ~600,000-citation dataset, Peec AI’s 30-million-source analysis, SEMrush’s 13-week cross-platform tracking, Profound’s six-model tracking, Evertune’s 200-million-prompt analysis, and Ahrefs’ 75,000-brand correlation study.

The Q2 2026 edition will layer 5W’s own primary research on top of this baseline — 1,500 fixed prompts (600 branded, 600 category, 300 executive) run across ChatGPT, Claude, Perplexity, Gemini, and Google AI Mode in a single calendar week, with every citation classified against a 12-bucket taxonomy and the full dataset published for public replication.

Read the Full Report

The 5W Citation Source Audit – Q1 2026: https://www.5wpr.com/research/citation-source-audit-q1-2026/Download PDF: https://www.5wpr.com/research/citation-source-audit-q1-2026/5W_Citation_Source_Audit_Q1_2026.pdfRequest a custom AI Visibility Audit: https://www.5wpr.com/contactus/

About 5W

5W is the AI Communications Firm, building brand authority across the platforms where decisions now happen — ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews — alongside earned media, digital, and influencer channels. 5W combines public relations, digital marketing, Generative Engine Optimization (GEO), and proprietary AI visibility research, helping clients measure and grow their presence in AI-driven buyer research.

Founded more than 20 years ago, 5W has been recognized as a top U.S. PR agency by O’Dwyer’s, named Agency of the Year in the American Business Awards®, and honored as a Top Place to Work in Communications in 2026 by Ragan. 5W serves clients across B2C sectors including Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, and Nonprofit; B2B specialties including Corporate Communications and Reputation Management; as well as Public Affairs, Crisis Communications, and Digital Marketing, including Social Media, Influencer, Paid Media, GEO, and SEO. 5W was also named to the Digiday WorkLife Employer of the Year list.

For more information, visit 5W.

Media Contact
Chris Bergin
cbergin@5wpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wikipedia-and-reddit-now-drive-over-25-of-chatgpt-citations-in-the-us-new-5w-research-finds–wsj-nyt-and-bloomberg-do-not-appear-in-the-top-20-302768339.html

SOURCE 5W Public Relations

Continue Reading

Technology

Riverside Partners Rebrands as RS2 Healthcare Partners; Closes Continuation Vehicle for Loftware

Published

on

By

Rebrand reflects strategic decision to focus exclusively on healthcare investing

Craig Stern appointed Co-Managing Partner of RS2 Healthcare Partners alongside David Belluck

AKKR Strategic Capital served as lead investor in Loftware Continuation Vehicle in a transaction that provides additional committed funding to support Loftware’s future growth and enables new platform investments

BOSTON, May 11, 2026 /PRNewswire/ — Riverside Partners, a private equity firm headquartered in Boston, is pleased to announce its rebrand to RS2 Healthcare Partners (the “Firm”), reflecting the Firm’s exclusive focus going forward on healthcare investing in the lower middle market. The new brand underscores the Firm’s longstanding and deepening commitment to investing in pharma services, medical device contract manufacturing, technology-enabled healthcare, and other high-growth healthcare subsectors.

RS2 Healthcare Partners builds on over 30 years of experience and formalizes the strategic decision to exclusively pursue investments with a healthcare orientation going forward. RS2 Healthcare Partners’ specialized strategy is supported by a highly experienced team of investment professionals alongside Healthcare, Clinical, and AI Advisory Boards comprising over 30 executives, clinicians, and technology experts from leading healthcare organizations.

David Belluck, Co-Managing Partner at RS2 Healthcare Partners, said, “RS2 Healthcare Partners reflects the investment strategy and sector specialization we have cultivated over three decades of focused lower middle market healthcare investing. Our dedicated healthcare platform — anchored by established industry relationships, an experienced investment team, and veteran Advisory Boards — creates a differentiated ability to partner with founders and management teams to build market-leading businesses. The rebrand reinforces our commitment to being the partner of choice to founders and management teams in the lower middle market and marks an important milestone in the evolution of our firm.”

The Firm also announced the appointment of Craig Stern as Co-Managing Partner, joining David Belluck in leading RS2 Healthcare Partners. Having worked alongside Mr. Belluck for 14 years with an exclusive focus on healthcare investing, Mr. Stern’s new role reflects both the depth of their partnership and the Firm’s dedication to building a world-class healthcare-focused investment platform.

Mr. Belluck added, “I am pleased to announce Craig Stern’s appointment as Co-Managing Partner of RS2 Healthcare Partners. Craig and I have worked side by side to build our healthcare investment platform, and his elevated role is a natural next step that is a testament to both the strength of our partnership and our shared commitment to the Firm’s continued growth.”

“We have been focused on creating a firm with a differentiated approach to healthcare investing, grounded in extensive sector expertise, a collaborative and values-driven culture, and trusted partnerships with founders and management teams,” said Craig Stern, Co-Managing Partner at RS2 Healthcare Partners. “We have deep conviction and a shared vision for the opportunity ahead and I am excited to co-lead the Firm going forward with David as we build on the strong foundation already in place.”

RS2 Healthcare Partners also completed a single-asset continuation vehicle (the “Continuation Vehicle”) for Loftware, Inc. (“Loftware” or the “Company”), a leading global enterprise labeling and artwork management provider of cloud-based software solutions. The transaction highlights the Firm’s healthcare expertise, as evidenced by Loftware’s life sciences vertical growing from a nascent business into Loftware’s largest and fastest-growing end-market and a key area for future growth. Accel-KKR’s (“AKKR”) dedicated secondary fund, AKKR Strategic Capital, served as lead investor of the Continuation Vehicle. The Continuation Vehicle provides Loftware with dedicated capital to support future growth. The transaction also provides RS2 Healthcare Partners with additional committed funding to pursue new platform investments.

RS2 Healthcare Partners originally acquired Loftware in 2014. Over the course of the investment, the Firm has supported the Company’s transformation from a US-focused labeling provider into the leading independent global platform offering mission-critical software and applications enabling its customers to design, deliver and trace labels across complex supply chains with significant regulatory and compliance requirements. During this period, Loftware completed four strategic add-on acquisitions that expanded its products and capabilities to establish an end-to-end, highly-integrated solution serving global supply chains. Loftware generates approximately $125 million in revenue and serves more than 10,000 customers across over 100 countries.

AKKR has been an investor in Loftware since March 2023, when the Firm sold a partial stake in the Company to AKKR. The Continuation Vehicle deepens this existing partnership and delivers meaningful benefits to all stakeholders. The transaction offered existing limited partners the options to maintain their existing investments or to receive liquidity or roll over their interests into the Continuation Vehicle with new unfunded capital commitments to support the Company’s growth plans.

Atlantic-Pacific Capital, Inc. served as exclusive financial advisor and placement agent, and Choate Hall & Stewart LLP served as legal counsel to RS2 Healthcare Partners.

About RS2 Healthcare Partners

Founded in 1989, RS2 Healthcare Partners (formerly Riverside Partners) is a Boston-based private equity firm with total capital commitments of $1.6 billion raised since inception. The Firm exclusively focuses on healthcare investing in the lower middle market. RS2 Healthcare Partners combines a disciplined investment strategy, specialized sector expertise, a highly experienced team of investment professionals and healthcare advisors, and a collaborative approach to partnering with founders and management teams. For more information, visit www.rs2healthcare.com.

About Loftware

Loftware is the global leader in product identification. Loftware’s cloud-based solutions power real-time collaboration, ensure compliance, improve authenticity, and deliver supply chain traceability from product development to consumer engagement. Loftware provides scalable, data-driven labeling and packaging technologies that help companies boost speed to market, enhance efficiency, and connect physical products to digital experiences. Trusted by global brands and backed by over 40 years of innovation, Loftware supports customers across industries with offices in the United States, United Kingdom, Slovenia, China, and Singapore. For more information, visit www.loftware.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/riverside-partners-rebrands-as-rs2-healthcare-partners-closes-continuation-vehicle-for-loftware-302768290.html

SOURCE Riverside Partners

Continue Reading

Technology

EnformionGO Launches Lead Builder to Simplify On-Demand Lead Sourcing

Published

on

By

EnformionGO has launched Lead Builder, a new on-demand solution that enables lead brokers and marketers to quickly build, price, and download highly targeted lead audiences in real time. Designed to eliminate reliance on fragmented vendors and outdated data sources, Lead Builder allows users to define audiences using a wide range of demographic, behavioral, property, and professional signals, with instant visibility into volume and pricing. The product gives teams greater control and speed in sourcing high-quality leads—helping brokers stabilize inventory and marketers create fresh, precise audiences for campaign execution. Powered by the EnformionGO platform and its unified identity intelligence, Lead Builder reflects a broader shift toward flexible, self-service lead generation and faster decision-making.

SACRAMENTO, Calif., May 11, 2026 /PRNewswire-PRWeb/ — EnformionGO, an Enformion brand, today announced the launch of EnformionGO Lead Builder, a new product designed to help businesses build, price, and download targeted lead audiences on demand.

“We built Lead Builder to remove friction from how teams access and use data,” said Jordan Manavian, VP of Product for EnformionGO. “With instant visibility into audience size and the ability to activate in real time, teams can move faster, whether they’re generating or fulfilling demand.”

The release addresses a common challenge across the lead generation ecosystem: sourcing high-quality leads quickly without relying on fragmented vendors, outdated data, or slow manual processes.

With Lead Builder, users can define a target audience using a combination of demographic, behavioral, property, and professional signals, instantly preview available volume and pricing, and download leads instantly—all from the EnformionGO platform.

“With EnformionGO Lead Builder, we’re giving customers a faster, more direct way to access the audiences they need,” said Chris Lundquist, CEO of Enformion. “Instead of waiting on suppliers or working through rigid purchasing models, teams can now generate and act on opportunities in real time.”

The product is designed to support both lead brokers and marketing teams, who often face similar constraints from different angles.

For brokers, Lead Builder enables on-demand creation of lead inventory, helping stabilize supply and reduce dependence on multiple external vendors. For marketers, it offers a way to move beyond static or overused datasets by quickly building new audiences for testing, targeting, and campaign execution.

“We built Lead Builder to remove friction from how teams access and use data,” said Jordan Manavian, VP of Product for EnformionGO. “Whether you’re fulfilling demand or trying to generate it, having immediate visibility into audience size and the ability to activate instantly changes how quickly you can move.”

The solution is powered by the EnformionGO platform, which brings together multiple data signals, including consumer, geographic, behavioral, property, and business intelligence into a single, unified experience, enabling users to build more precise, actionable audiences in real time.

The launch reflects a growing shift toward more flexible, on-demand approaches to lead generation, as businesses look to move faster and operate with greater control over lead audiences and performance.

EnformionGO Lead Builder is now available as part of the EnformionGO platform.

About EnformionGO

EnformionGO is a self-service platform that provides fast, flexible access to comprehensive identity intelligence. Powered by Enformion’s proprietary identity graph, EnformionGO enables businesses to search, enrich, and integrate high-quality consumer, business, and public records data through intuitive tools, APIs, batch processing, and its Lead Builder solution. This empowers faster, more confident decision-making with reliable, real-time insights.

Media Contact

Christine Rhodes, EnformionGO, 1 913-634-6657, christine.rhodes@enformion.com, https://go.enformion.com/

View original content:https://www.prweb.com/releases/enformiongo-launches-lead-builder-to-simplify-on-demand-lead-sourcing-302766599.html

SOURCE EnformionGO

Continue Reading

Trending